Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Neuberg Centre For Genomic Medicine, |
RCV003337973 | SCV004048448 | likely pathogenic | Focal segmental glomerulosclerosis 2 | criteria provided, single submitter | clinical testing | The frameshift c.1090dup (p.Ser364LysfsTer8) variant in TRPC6 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Ser364LysfsTer8 variant is novel (not in any individuals) in gnomAD Exomes and 1000 Genomes. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been reported previously to be disease causing (Reiser et al,2005). For these reasons, this variant has been classified as Likely Pathogenic. |